Aquestive Therapeutics (AQST) Price to Sales (2018 - 2026)
Aquestive Therapeutics' (AQST) Price to Sales stood at 9.65 in Q2 2026, up 29.5% from 7.45 a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Price to Sales (2018 - 2026) Analysis & Trends
For FY2025, Aquestive Therapeutics' Price to Sales came in at 17.70, up 213.1% from FY2024.
- Annual Price to Sales has increased for three straight years.
- Across earlier years, Price to Sales came in at 5.65 in FY2024 (+106.6%), 2.74 in FY2023 (+164.4%), 1.03 in FY2022 (-67.2%) and 3.16 in FY2021 (-21.8%).
- Quarterly Price to Sales has ranged from 0.68 in Q2 2022 to 17.70 in Q4 2025 over the past five years.
- On a year-over-year basis, Price to Sales has increased for five consecutive quarters, with growth averaging 109.9% over the last eight quarters.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 344.6% in Q1 2024, against a decline of 81.3% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 10.26 (Q1 2026), 17.70 (Q4 2025) and 15.67 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aquestive Therapeutics | 571.08 Mn | 111.62 Mn | 9.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.65 |
| Mar 31, 2026 | 10.26 |
| Dec 31, 2025 | 17.70 |
| Sep 30, 2025 | 15.67 |
| Jun 30, 2025 | 7.45 |
| Mar 31, 2025 | 5.31 |
| Dec 31, 2024 | 5.65 |
| Sep 30, 2024 | 7.71 |
| Jun 30, 2024 | 4.06 |
| Mar 31, 2024 | 6.09 |
| Dec 31, 2023 | 2.74 |
| Sep 30, 2023 | 2.12 |
| Jun 30, 2023 | 2.19 |
| Mar 31, 2023 | 1.37 |
| Dec 31, 2022 | 1.03 |
| Sep 30, 2022 | 1.31 |
| Jun 30, 2022 | 0.68 |
| Mar 31, 2022 | 2.09 |
| Dec 31, 2021 | 3.16 |
| Sep 30, 2021 | 3.73 |
API Access
Aquestive Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();